Closed Loop Medicine Ltd | Reg: 10584642 | Created: 2017-01-26 | Status: active | Type: ltd Located at 3rd Floor 1 Ashley Road, Altrincham, WA14 2DT, we are a focused, research-driven biotechnology company dedicated to revolutionizing personalized medicine. Established in 2017, we specialize in the development and commercialization of innovative solutions leveraging advanced data analytics and precision dosing technologies. Our core business centers around creating proprietary algorithms and device integrations that optimize medication delivery for individual patients. We achieve this through a closed-loop system, continuously monitoring patient response and adjusting dosage in real-time. This approach aims to minimize adverse effects, maximize therapeutic efficacy, and improve patient outcomes. We are currently focused on a specific niche within the medical field – optimizing treatment regimens for chronic conditions – and are actively exploring applications across multiple therapeutic areas. Our current strategy involves a skilled worker role, with a rating of A, and we are committed to expanding our international presence through strategic partnerships and collaborations. We operate within the following SIC codes: - 72110: Research and experimental development on biotechnology, - 6461: Pharmaceutical research and development, - 6462: Clinical diagnostics and testing.

Closed Loop Medicine Ltd | Reg: 10584642 | Created: 2017-01-26 | Status: active | Type: ltd Located at 3rd Floor 1 Ashley Road, Altrincham, WA14 2DT, we are a focused, research-driven biotechnology company dedicated to revolutionizing personalized medicine. Established in 2017, we specialize in the development and commercialization of innovative solutions leveraging advanced data analytics and precision dosing technologies. Our core business centers around creating proprietary algorithms and device integrations that optimize medication delivery for individual patients. We achieve this through a closed-loop system, continuously monitoring patient response and adjusting dosage in real-time. This approach aims to minimize adverse effects, maximize therapeutic efficacy, and improve patient outcomes. We are currently focused on a specific niche within the medical field – optimizing treatment regimens for chronic conditions – and are actively exploring applications across multiple therapeutic areas. Our current strategy involves a skilled worker role, with a rating of A, and we are committed to expanding our international presence through strategic partnerships and collaborations. We operate within the following SIC codes: - 72110: Research and experimental development on biotechnology, - 6461: Pharmaceutical research and development, - 6462: Clinical diagnostics and testing.